Prothena Ownership | Who Owns Prothena?
Prothena Ownership Summary
Prothena is owned by 94.57% institutional investors, 12.42% insiders. Ecor1 capital is the largest institutional shareholder, holding 21.57% of PRTA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.13% of its assets in Prothena shares.
PRTA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Prothena | 94.57% | 12.42% | -6.99% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 3.30M | 6.13% | 19.54K |
Fidelity Growth Compy Commingled Pl O | 3.28M | 6.09% | 1.22K |
Vanguard Health Care Inv | 3.25M | 6.03% | 851.12K |
Fidelity Growth Company Fund | 2.35M | 4.38% | -5.00K |
US Small-Cap Growth II Equity Comp | 1.89M | 3.52% | -6.73K |
T. Rowe Price New Horizons | 1.89M | 3.52% | -5.96K |
iShares Russell 2000 ETF | 1.09M | 2.02% | -2.44K |
Fidelity Growth Company K6 | 842.82K | 1.57% | -14.54K |
Fidelity Series Growth Company | 758.61K | 1.41% | - |
Fidelity Select Biotechnology | 738.12K | 1.37% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 24, 2024 | Walker Karin L | Chief Accounting Officer | Sell | $170.00K |
Dec 20, 2023 | Walker Karin L | Chief Accounting Officer | Sell | $124.41K |
Dec 20, 2023 | Walker Karin L | Chief Accounting Officer | Sell | $61.54K |
Nov 30, 2023 | Walker Karin L | Chief Accounting Officer | Sell | $170.00K |
Oct 25, 2023 | Walker Karin L | Chief Accounting Officer | Sell | $72.04K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 1 |
2023 Q4 | - | 10 |
PRTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools